IgA Vasculitis Complicated by Both CMV Reactivation and Tuberculosis

• Main Authors: Małgorzata Mizerska-Wasiak (Author), Maria Winiarska (Author), Karolina Nogal (Author), Karolina Cichoń-Kawa (Author), Małgorzata Pańczyk-Tomaszewska (Author), Jadwiga Małdyk (Author)
• Format: Book
• Published: MDPI AG, 2021-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.
• Notes: 10.3390/pediatric13030048; 2036-7503
• Keywords: tuberculosis; CMV; IgA nephropathy; IgA vasculitis; proteinuria; immunosuppressive therapy; Medicine; R; Pediatrics; RJ1-570
• Source: Pediatric Reports, Vol 13, Iss 3, Pp 416-420 (2021)

Immunoglobulin A (IgA) vasculitis is the most common systemic vasculitis in the pediatric population. We present the case of a patient with IgA vasculitis with nephritis who developed cytomegalovirus (CMV) infection followed by Mycobacterium tuberculosis infection. In the literature, there are a few cases of IgA nephropathy accompanied by reactivation of CMV or tuberculosis. To the best of our knowledge, this is the first reported case of IgA vasculitis complicated by both CMV reactivation and tuberculosis. It is important to detect infections in patients with IgA vasculitis because they can induce and exacerbate the symptoms of the disease. Effective antimicrobial treatment facilitates the management of proteinuria and slows down the decline of renal function. Immunosuppressive therapy is a risk factor for reactivation of latent infections and makes patients more susceptible to its generalized and complicated course. This can be prevented by actively screening for hidden sites of infection.